Barcelona-based Health Lean Analytics, a healthcare data automation startup, has raised more than €2.1 million in total funding as it looks to scale its AI-driven platform designed to streamline hospital operations and improve clinical decision-making.
The funding round combines private investment and public support. Novanta joined as both a strategic and technology partner, bringing expertise in manufacturing and medical technologies as well as access to the U.S. market. Several family offices, including Inderhabs, Namarel Ventures, and Braincats, participated in an oversubscribed €1.4 million seed round. The company also secured a participative loan from ENISA.
Founded in 2023, Health Lean Analytics develops a platform that automates the capture of clinical and operational data within hospitals, particularly in surgical environments. Its system integrates with existing hospital infrastructure to unify data across patients, operating rooms, materials, medications, and equipment.
The platform uses artificial intelligence, large language models, and operational agents to transform raw hospital data into real-time insights and recommended actions. By identifying patterns, predicting deviations, and guiding decision-making, the system aims to reduce costs, improve surgical capacity, enhance patient safety, and free up clinicians’ time.
A key differentiator is its ability to passively collect data without requiring manual input from healthcare staff, addressing one of the biggest inefficiencies in hospital operations. The company’s focus on operating rooms targets one of the most complex and resource-intensive areas in healthcare systems.
With the new capital, Health Lean Analytics plans to expand internationally, with the United States as its primary target market. The company is aiming to begin commercial deployment there within the next 12 months while continuing to invest in research and development to enhance its data automation and AI capabilities.
KEY QUOTE:
“The incorporation of Novanta as an advanced technology partner validates our technological and strategic strength and provides us with the resources and expertise needed to accelerate our R&D innovation. With this support, we will be able to initiate commercial deployment in the United States, a key market, and demonstrate how our technology transforms hospital management by increasing efficiency, safety and quality of patient care. This alliance undoubtedly marks the beginning of a new phase of international growth and the consolidation of our position as a benchmark in the sector.”
Mauro Batesteza, Co-Founder And Co-CEO Of Health Lean Analytics
